Back to Journals » OncoTargets and Therapy » Volume 11

TIM-3, a promising target for cancer immunotherapy

Total article views   HTML views PDF downloads Totals
36,316 Dovepress* 14,937+ 2,175 17,112
PubMed Central* 21,379 2,931 24,310
Totals 36,316 5,106 41,422
*Since 16 October 2018
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 1 5

View citations on PubMed Central and Google Scholar